Tyra Biosciences Statistics
Total Valuation
TYRA has a market cap or net worth of $2.09 billion. The enterprise value is $1.84 billion.
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TYRA has 59.49 million shares outstanding. The number of shares has increased by 4.17% in one year.
| Current Share Class | 59.49M |
| Shares Outstanding | 59.49M |
| Shares Change (YoY) | +4.17% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 2.68% |
| Owned by Institutions (%) | 61.45% |
| Float | 31.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 7.27 |
| P/TBV Ratio | 8.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.67, with a Debt / Equity ratio of 0.02.
| Current Ratio | 14.67 |
| Quick Ratio | 14.25 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -39.83% and return on invested capital (ROIC) is -27.01%.
| Return on Equity (ROE) | -39.83% |
| Return on Assets (ROA) | -25.68% |
| Return on Invested Capital (ROIC) | -27.01% |
| Return on Capital Employed (ROCE) | -50.19% |
| Weighted Average Cost of Capital (WACC) | 9.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.38M |
| Employee Count | 87 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +249.20% in the last 52 weeks. The beta is 0.96, so TYRA's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +249.20% |
| 50-Day Moving Average | 35.54 |
| 200-Day Moving Average | 22.47 |
| Relative Strength Index (RSI) | 45.65 |
| Average Volume (20 Days) | 1,089,920 |
Short Selling Information
The latest short interest is 7.71 million, so 12.96% of the outstanding shares have been sold short.
| Short Interest | 7.71M |
| Short Previous Month | 8.26M |
| Short % of Shares Out | 12.96% |
| Short % of Float | 24.60% |
| Short Ratio (days to cover) | 7.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -132.76M |
| Pretax Income | -119.95M |
| Net Income | -119.95M |
| EBITDA | -132.22M |
| EBIT | -132.76M |
| Earnings Per Share (EPS) | -$2.01 |
Full Income StatementBalance Sheet
The company has $256.00 million in cash and $5.81 million in debt, giving a net cash position of $250.19 million or $4.21 per share.
| Cash & Cash Equivalents | 256.00M |
| Total Debt | 5.81M |
| Net Cash | 250.19M |
| Net Cash Per Share | $4.21 |
| Equity (Book Value) | 259.18M |
| Book Value Per Share | 4.83 |
| Working Capital | 247.36M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$95.14 million and capital expenditures -$141,000, giving a free cash flow of -$95.28 million.
| Operating Cash Flow | -95.14M |
| Capital Expenditures | -141,000 |
| Depreciation & Amortization | 546,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -95.28M |
| FCF Per Share | -$1.60 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |